FAPI Imaging Assessment of Chronic Total Occlusion

RecruitingOBSERVATIONAL
Enrollment

167

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Chronic Total Occlusion (CTO)
Interventions
DIAGNOSTIC_TEST

FAPI Imaging

Studies have shown that imaging with radionuclide-labeled fibroblast activation protein inhibitor (FAPI) is a reliable technique for detecting myocardial fibrosis and activated CFs in arteries. Preliminary evidence suggests that FAPI imaging can assess plaque characteristics and the status of myocardial fibrosis in various cardiovascular diseases.

Trial Locations (2)

100020

RECRUITING

Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, Beijing

RECRUITING

Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, Beijing

All Listed Sponsors
collaborator

Beijing Chao Yang Hospital

OTHER

lead

Lin Zhao

OTHER